Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Kringle Pharma hits daily limit up on patent registration for chronic spinal cord injury treatment
Kringle Pharma,Inc. <4884> surged to its daily limit up of \80 above the previous trading day's close and remained locked at bid-only quotation at that level. On the 1st, the company announced that a patent related to a new treatment for chronic spinal cord injury, jointly filed with Keio University, has been registered in Japan. The announcement attracted buying interest. The patent is based on research findings that demonstrated recovery of motor function and urinary function through the combined use of human iPS-derived cell transplantation developed by Keio University and a scaffold containing hepatocyte growth factor (HGF) developed by Kringle Pharma. The company is currently advancing the development of an HGF-based therapeutic drug for acute spinal cord injury and is preparing for an additional Phase 3 clinical trial.
Source: MINKABU PRESS
Related Articles
LIFEDRINK COMPANY falls for first time in 5 days as profit-taking outweighs Iris Ohyama's consecutive stake increase reports
CHUGAI PHARMA extends gains as U.S. FDA approves Eli Lilly's oral obesity drug Founayo
Vitabrid Japan debuts at \1,301, 5.0% below IPO price
QPS HD, Astroscale HD and other space development-related stocks surge on successful Artemis launch attracting investment flowsâ—‡
Active Stocks (Close): SAMCO, REFINVERSE Group, Nxera Pharma and others
V-cube hits daily limit down amid \40 squeeze-out plan
ANRITSU shares rebound sharply on plan to consolidate French subsidiary SmartViser, expand business opportunities
YE DIGITAL shares surge on record profit forecast and \10 dividend increase for FY Feb 2027
Tokyo Stocks (Morning Open) - Continue Higher at Start, Buying Leads on U.S. Stock Gains
AMG HOLDINGS rises for first time in 5 days on upward revision to operating profit forecast for March 2026